Corden Pharma - A Full-Service CDMO’s Post

View organization page for Corden Pharma - A Full-Service CDMO, graphic

32,845 followers

> Press Release 19 June: WACKER & CordenPharma are pleased to announce their joint consortium has officially entered the pandemic readiness state as of 1 June 2024. Following a successful expansion and qualification phase, the companies are now in stand-by phase for at least five years. In the event of a new pandemic, WACKER and CordenPharma have taken the necessary steps to produce 80 million vaccine doses a year within an extremely short time, with most of the production steps taking place in Germany, and every production step occurring within the European Union. As part of the consortium, CordenPharma is ready to manufacture custom and standard lipids in our Frankfurt (DE) and Chenôve (FR) sites, as well as provide aseptic fill & finish and packaging of the chosen mRNA-based vaccine at our Caponago (IT) facility. In its site in Halle (Germany), WACKER will produce plasmid DNA (pDNA), which is an essential starting material for the manufacture of mRNA. Dr. Michael Quirmbach, CEO of CordenPharma Group, commented: “Obtaining the official confirmation of pandemic readiness by the German government is a major milestone for CordenPharma. I am extremely proud of our teams across the CordenPharma sites involved in establishing and delivering our pandemic readiness plan on schedule. We are now ready, together with our partner WACKER, to manufacture end-to-end mRNA-based vaccines for the German government and other customers.” “We have expanded our Halle site into a Competence Center for mRNA production,” said WACKER CEO Dr. Christian Hartel. “WACKER has invested over 100 million Euros in this expansion and created over 100 highly qualified jobs. Our expertise in making mRNA and LNPs will contribute to the fight against future pandemics. Together with CordenPharma, we are proud to serve the German government in its pandemic preparedness plans.” Read the full press release here: https://lnkd.in/d6vBdaPK #CordenPharma #wacker #pandemic #mrna #pdna #lipids #injectables #fillfinish #pharmaceuticals #vaccine #germany

Wacker & CordenPharma Enter Pandemic Readiness 1 June 2024 | CordenPharma

Wacker & CordenPharma Enter Pandemic Readiness 1 June 2024 | CordenPharma

cordenpharma.com

Reischer Nicolas

Vice President, General Counsel bei HOOKIPA Pharma

2w

Well done! So proud of the Wacker & CordenPharma teams.

Frank Scholdann Lund - Industrial decarbonisation and boiler improvement

High performing and low emitting boilers and plants? Click connect

2w

Congratulations with joint work - this seems like a good business approach to both companies - congratulations to both of you 👍

Monika Brazda

Partner at Quality Biotech - Development & Cells (QBDC)

2w

Congratulations! Well done, but I hope the next pandmic takes som time 😉

Like
Reply
Frank Rauschen

Exexcutive Director Global Strategy Biologics and Cell&Gene Therapy at Novartis

2w

Congratulations!

See more comments

To view or add a comment, sign in

Explore topics